Controlled-release oxycodone improves pain management after uterine artery embolisation for symptomatic fibroids

Imagem de Miniatura
Arquivos
art_FREIRE_Controlledrelease_oxycodone_improves_pain_management_after_uterine_artery_2017.PDF (387.99 KB)
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2017
Editora
W B SAUNDERS CO LTD
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
FREIRE, G. M. G.
CAVALCANTE, R. N.
MOTTA-LEAL-FILHO, J. M.
GALASTRI, F. L.
AFFONSO, B. B.
ROCHA, R. D.
NASSER, F.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CLINICAL RADIOLOGY, v.72, n.5, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
AIM: To evaluate if pre-and post-procedure administration of controlled-release oxycodone (CRO) in combination with standard analgesia improves pain control and decreases the amount of required post-procedure opioids in uterine fibroid embolisation (UFE). MATERIALS AND METHODS: Between January 2009 and March 2010, 60 consecutive women were prospectively randomised in two groups for UFE: the control group, in which 30 patients underwent the standard anaesthetic procedure and the CRO group, in which 30 patients underwent the standard anaesthetic procedure with the addition of CRO. Age, pain, nausea/ vomiting, fibroid volume, length of hospital stay, and use and dose of morphine received via the patient-controlled analgesia (PCA) device in both groups were evaluated to compare the two methods of pain control. Fibroid volume as measured at magnetic resonance imaging (MRI) was evaluated for correlation with post-embolisation pelvic pain over a period of 24 hours. RESULTS: A significant difference was seen in the pain scores at 24 hours (p = 0.029), with less pain in the CRO group. More patients from the control group required morphine (p = 0.017), and at higher levels (p = 0.130). Pruritus was lower in patients of the CRO group, probably because they received less morphine (p = 0.029). No correlation was seen between leiomyoma volume and pain levels over 24 hours (Spearman's r = 0.02; p = 0.881). Length of hospital stay was not different between the two groups. CONCLUSION: The addition of CRO to standard analgesia for UFE provides more effective analgesia, with a reduction in pain scores in 24 hours, less morphine use, and decreased side effects, mainly pruritus.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/20222
Referências
  1. Blumenthal S, 2007, ANESTH ANALG, V105, P233, DOI 10.1213/01.ane.0000266451.77524.0d
  2. Bratby MJ, 2008, BEST PRACT RES CL OB, V22, P717, DOI 10.1016/j.bpobgyn.2008.01.013
  3. Gulle Eva, 2011, Patient Saf Surg, V5, P10, DOI 10.1186/1754-9493-5-10
  4. Hehenkamp WJK, 2006, CARDIOVASC INTER RAD, V29, P179, DOI 10.1007/s00270-005-0195-9
  5. Kim H, 2008, CARDIOVASC INTER RAD, V31, P1100, DOI 10.1007/s00270-008-9430-5
  6. Konstantatos AH, 2014, CARDIOVASC INTER RAD, V37, P1191, DOI 10.1007/s00270-014-0913-2
  7. McDonnell NJ, 2010, INT J OBSTET ANESTH, V19, P16, DOI 10.1016/j.ijoa.2009.03.004
  8. Nasser F, 2014, J VASC INTERV RADIOL, V25, P1012, DOI 10.1016/j.jvir.2014.02.025
  9. RAVINA JH, 1995, LANCET, V346, P671, DOI 10.1016/S0140-6736(95)92282-2
  10. Siskin GP, 1999, J VASC INTERV RADIOL, V10, P891, DOI 10.1016/S1051-0443(99)70133-8
  11. Sunshine A, 1996, J CLIN PHARMACOL, V36, P595
  12. van der Kooij SM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.016
  13. Volkers NA, 2006, J VASC INTERV RADIOL, V17, P471, DOI 10.1097/01.RVI.0000203419.61593.84
  14. Walker WJ, 2002, BJOG-INT J OBSTET GY, V109, P1262, DOI 10.1016/S1470-0328(02)01949-3
  15. Zupi E, 2003, FERTIL STERIL, V79, P107, DOI 10.1016/S0015-0282(02)04399-6

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC